Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Taking Saw palmetto and Pygeum africana can change the levels of certain steroids in urine, which could cause confusion in doping tests.

Mercury can disrupt sex hormones and cause reproductive issues.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Consider benefits and risks of new alopecia treatments for safety.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Anabolic-androgenic steroids increase the risk of heart problems.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Physical activity, height, and smoking affect prostate cancer risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Men with male pattern baldness have a higher risk of dying from prostate cancer.